SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD OCT 05
MCX SILVER SEP 04
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD OCT 05
MCX SILVER SEP 04
MCX CRUDEOIL AUG 19
MCX NATURALGAS AUG 26
USD/INR
EUR/INR
GBP/INR
JPY/INR

Closing Bell: Indices end higher amid volatility; Nifty above 11,200

Global stocks on defensive as US-China tensions spook investors

Oil prices slip on uncertainty over US recovery, stimulus

Rupee ends marginally lower; appreciates by 0.24% for the week

Auto

Fight against COVID-19: Government seeks auto companies’ help for making ventilators

Updated : March 25, 2020 05:29 PM IST

Companies like Maruti Suzuki, Mahindra and Mahindra, Tata Motors and Hyundai have been approached.

Tata Group and M&M have already started doing the groundwork for making ventilators.

The Centre has started reaching out to top automobile manufacturers as well as auto parts companies seeking their help in ramping up production of ventilators and other medical gear that can help in fighting the spread of COVID-19.

Sources told CNBC-TV18 that the Ministry of Heavy Industries and Department of Pharmaceuticals have already reached out to companies like Maruti Suzuki, Mahindra and Mahindra, Tata Motors and Hyundai. More companies will be approached, the sources said.

Companies like Tata Group and M&M have already started doing the groundwork for making ventilators.

In an interview to CNBC-TV18, N Chadrasekaran, Chairman, Tata Sons said, "Tata Group is looking at setting up a plant to manufacture ventilators. We are working on this on priority. Tata Hospitals will add another one thousand beds soon".

A Tata Group spokesperson did not elaborate on the company's plan to setup a ventilator manufacturing unit.

Mahindra Group Chairman, Anand Mahindra recently said on Twitter, "To help in the response to this unprecedented threat, we at the Mahindra Group will immediately begin work on how our manufacturing facilities can make ventilators. At Mahindra Holidays, we stand ready to offer our resorts as temporary care facilities".

While other OEMs are considering the possibility, they do feel that the time available is too short.

Speaking to CNBC TV18, RC Bhargava, Chairman Maruti Suzuki said, "The govt anticipates a need for a much larger number of ventilators. They have approached us about the possibility of making ventilators in house. A number of our teams are looking at the possibility. We will come up with an answer in a day or two. We have very limited time."

Automobile industry bodies have been sounded out as well.

Vinnie Mehta, Director General of Automotive Components Manufacturers Association said, "The Secretary, Heavy Industries has reached out to ACMA on how the components industry can help in making masks, sanitizers, and ventilators". Mehta said the association is discussing the matter internally and has sought more details from the government on specifications, prototype, and quantity of medical goods that are required.

The companies CNBC-TV18 spoke to felt that it may better to import such devices from countries like China which have ready stock.

AK Taneja, MD, Shriram Pistons and Rings said, "In the near term it may be more desirable to import ventilators, as the process of design, manufacturing, testing and approvals may take several weeks. We are working on a plan and are exploring the possibility of importing ventilators and donating to the government as part of our CSR contributions"

DPIIT Secretary Guruprasad Mohapatra told CNBC-TV18 on Wednesday, "Pharma department has made a list of all ventilator manufacturers in India. A group of joint secretaries also looking at ramping up ventilator production in India".

Note: This story has been updated with quotes from Maruti Suzuki and Shriram Pistons and Rings

Track our full coverage of the cornavirus pandemic here.

You May Also Like

Adani Transmission Q1 profit up 67% at Rs 355 crore

Adani Transmission Q1 profit up 67% at Rs 355 crore

This mid-cap pharma stock turned Rs 1,00,000 to Rs 3,17,000 in just four months

This mid-cap pharma stock turned Rs 1,00,000 to Rs 3,17,000 in just four months

Emami reports over 1% rise in Q1 profit at Rs 39 crore

Emami reports over 1% rise in Q1 profit at Rs 39 crore

Trending on CNBC-TV18

Live TV

recommended for you